TESTOSTERONE
| Brand name | VOGELXO |
|---|---|
| Active ingredient | TESTOSTERONE |
| Strength | 12.5MG/1.25GM ACTUATION |
| Dosage form | GEL, METERED |
| Route | TRANSDERMAL |
| Modality | Small molecule |
| FDA approval | June 2014 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 8785426 | February 2034 | product |
| 9662340 | February 2034 | product |
| 9295675 | February 2034 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.